DRUGS FOR IMPROVING ABILITY OF DAILY LIFE BEHAVIORS IN ALZHEIMER'S DISEASE

Drugs for improving the ability of daily life behaviors in Alzheimer's disease at the light or medium severity which contain, as the active ingredient, ipidacrine (9-amino- 2,3,5,6,7,8-hexahydro-1H-cyclopenta (b) quinoline), its pharmacologically acceptable salt or a hydrate of ipidacrine or it...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHIMADA, KAZUHIDE, SUMI, TAKAHIKO, YAMANA, KENJIROU, UMEDA, YURI, TAKAMATSU, YUKIO, OHSE, TAKUHITO, FUJINUKI, YASUHIRO, ISHII, YUTAKA, ISHIZAKI, SATORU, UESUGI, KEN, OHZEKI, MITSUO, SHIMIZU, JYUN
Format:	Patent
Sprache:	eng ; fre ; jpn
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Drugs for improving the ability of daily life behaviors in Alzheimer's disease at the light or medium severity which contain, as the active ingredient, ipidacrine (9-amino- 2,3,5,6,7,8-hexahydro-1H-cyclopenta (b) quinoline), its pharmacologically acceptable salt or a hydrate of ipidacrine or its pharmacologically acceptable. Cette invention concerne des médicaments améliorant les comportements de la vie courante chez des personnes atteintes de la maladie d'Alzheimer à un stade léger à moyennement grave, qui renferment comme principe actif de l'ipidacrine (9-amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinoline), un sel pharmaceutiquement acceptable de ce composé ou un hydrate d'ipidacrine ou un sel de ce composé pharmaceutiquement acceptable.